Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research

Optogenetics and cell replacement in retinology : Regenerative ophthalmology-What we can do!
Ophthalmologe. 2022 May 10. doi: 10.1007/s00347-022-01631-5. Online ahead of print.ABSTRACTFor many degenerative retinal diseases that progressively lead to blindness, no treatment options are available so far. In recent years, several innovative therapies have been experimentally explored, which are promising because they are independent of the genetic cause of the degenerative disease. One of these is optogenetics, which involves light-sensitive proteins that selectively act as ion channels or ion pumps to control the potential of the treated cell. Thus, these cells can be stimulated or inhibited by light, quasi function...
Source: Der Ophthalmologe - May 10, 2022 Category: Opthalmology Authors: Volker Busskamp Sarah Kunze Source Type: research